Pharmafile Logo

News and Press Releases

Thermo Fisher Scientific Showcases Clinical Research Innovation at DIA Annual Meeting

PPD clinical research business leads real-world data and technology panel, receives CRO Leadership Award 17 June 2024 -- California, US -- The PPD clinical research business of Thermo Fisher Scientific,...

Category: Clinical Trials, Drug Discovery, Pharmaceutical
Posted: June 17, 2024

Thermo Fisher Scientific
168 Third Avenue Waltham, MA 02451

Bio-Rad Launches First Ultrasensitive Multiplexed Digital PCR Assay for Breast Cancer Mutation Detection in Clinical Research

Highly Sensitive and Multiplexed Assay for the Detection, Discrimination and Quantification of Key Mutations in ESR1 Gene for Breast Cancer, Developed for Bio-Rad’s QX600 Droplet Digital PCR System 2 April...

Category: Clinical Trials
Posted: April 2, 2024

Bio-Rad
UK_contact@bio-rad.com
Bio-Rad Laboratories Ltd. The Junction Station Road Watford Hertfordshire WD17 1ET

One2Treat launches ground-breaking treatment-decision approach to clinical research and market access analysis

One2Treat reflects patient priorities in a single comprehensive treatment evaluation, reducing trial sample size and accelerating patient access to new treatments 26 March 2024 -- Brussels, Belgium -- One2Treat, a...

Category: Clinical Trials, Pharmaceutical
Posted: March 26, 2024

One2Treat
info@one2treat.com
Rue Emile Francqui, 1-1435 Mont-Saint-Guibert, Belgium

WCG Expands New Statistical Consulting Solutions to Address Industry Resource Challenges

4 March 2024 -- New Jersey, US -- WCG, the global leader in providing solutions that measurably improve and accelerate clinical research, announces the expansion of its capabilities with the...

Category: Clinical Trials
Posted: March 4, 2024

WCG Clinical
info@wcgclinical.com
212 Carnegie Center, Suite 301, Princeton, NJ 08540, USA

First MYC inhibitor to demonstrate safety and anti-tumour activity in a phase 1 first-in-human clinical trial

Developed in-house by VHIO-born spin-off company Peptomyc, OMO-103 is a mini-protein targeting the MYC oncogene which is found deregulated in most, if not all tumor types. Until recently, MYC has...

Category: Drug Discovery
Posted: February 7, 2024

Peptomyc
lsoucek@peptomyc.com
C/ Natzaret, 115-117 Barcelona, Spain, 08035

Thermo Fisher Scientific Announces Launch of Innovative CorEvitas Pharmacovigilance Platform for Clinical Research Registries

20 December 2023 -- Massachusetts, US -- Thermo Fisher Scientific, the world leader in serving science, today announced the launch of CorEvidence, a proprietary cloud-based data lake platform optimising pharmacovigilance...

Category: Clinical Trials
Posted: December 20, 2023

Thermo Fisher Scientific
168 Third Avenue Waltham, MA 02451

Bio-Rad Extends Range of Anti-Idiotypic Antibodies for Use in Preclinical and Clinical Drug Development

Range of Highly Selective Anti-Idiotypic Antibodies Now Includes Six Antibodies Specific to Dupilumab and its Biosimilars for Bioanalysis and Drug Monitoring 5 October 2023 -- California, US -- Bio-Rad Laboratories,...

Category: Drug Discovery
Posted: October 5, 2023

Bio-Rad
UK_contact@bio-rad.com
Bio-Rad Laboratories Ltd. The Junction Station Road Watford Hertfordshire WD17 1ET

Bio-Rad Launches PTC Tempo 48/48 and PTC Tempo 384 Thermal Cyclers 

Superior thermal performance and enhanced usability for PCR applications, such as sequencing, cloning and genotyping.  28 September 2023 -- California, US -- Bio-Rad Laboratories, a global leader in life science...

Category: Drug Discovery
Posted: September 28, 2023

Bio-Rad
UK_contact@bio-rad.com
Bio-Rad Laboratories Ltd. The Junction Station Road Watford Hertfordshire WD17 1ET